Journal
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
Volume 29, Issue 1, Pages 67-69Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.sder.2010.03.003
Keywords
-
Categories
Ask authors/readers for more resources
The year 2010 marks 8 years since etanercept obtained approval from the Food and Drug Administration for the treatment of psoriatic arthritis. There are 6 biologic therapies approved by the Food and Drug Administration for the treatment of psoriasis and/or psoriatic arthritis. These biologics are often used in patients who have received, are receiving, or will receive in the future the traditional systemic antipsoriatics. In this article, the currently available data on combining these therapies are reviewed. Semin Cutan Med Surg 29:67-69 (C) 2010 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available